Department of Cardiology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, China.
Department of Cardiology, The First Hospital of Changsha, Hunan Changsha, China.
Cardiovasc Res. 2019 Jun 1;115(7):1189-1204. doi: 10.1093/cvr/cvy231.
A recent study reported the cardioprotective effects mediated by cardiac fibroblasts (CFs) during acute phase of ischaemia-reperfusion injury (IRI). Little is known about whether exosomes/microvesicles mediate this beneficial effect and whether ischaemia post-conditioning (Postcon) can regulate this process. Here, we aimed to investigate the cardioprotective effect of CFs-exosomes/microvesicles and whether Postcon can regulate this effect.
By using transwells co-culture system, we found that hypoxia-reoxygenation (H/R) significantly increased the exosomes/microvesicles secretion of CFs and CFs protected H9C2 cells against H/R injury and Postcon could amplify these effects. Inhibition of CFs exosomes/microvesicles secretion led to a significant abrogation on the amplified protective effect of H/R-Postcon. We further demonstrated that Postcon enhanced the cardioprotective effect of CFs-exosomes/microvesicles both in vitro and in vivo. To detect the underlying mechanism, exosomes/microvesicles microRNAs were analysed by RNA sequencing and quantitative polymerase chain reaction, our results revealed that miR-423-3p expression was selectively enhanced by Postcon in CFs exosomes/microvesicles. By co-culture H9C2 cells with CFs-exosomes/microvesicles enriching with miR-423-3p, we demonstrated that H/R-Postcon exerted cardioprotective effects by upregulation of miR-423-3p in CFs-exosomes/microvesicles. RNA-fluorescence in situ hybridization and qPCR demonstrated that the decreasing of miR-423-3p is closely related to IRI, by inhibited miR-423-3p expression with its antagomir in vivo, we demonstrated that miR-423-3p plays an essential mediate role in I/R-Postcon-induced cardioprotection against I/R in vivo, Postcon may exert cardioprotective effect by upregulation of miR-423-3p in CFs exosomes/microvesicles. Gain- and loss-of-function approaches suggested that rescuing the down-regulated miR-423-3p might be a potential strategy to protect the cardiomyocytes against H/R. Using computational predictions tools and luciferase reporter assay, we demonstrated that miR-423-3p regulates the expression of Ras-related protein Rap-2c (RAP2C) in H9C2 cells, and knockdown of RAP2C by siRNA obviously increased cell viability and reduced apoptosis in H9C2 cells under H/R.
In conclusion, we demonstrated, for the first time, that CFs participate in cardioprotective effects via an exosomes/microvesicles pathway during the acute phase of IRI and Postcon can enhance this effect by upregulating the expression of CFs exosomes/microvesicles miR-423-3p, which targets the downstream effector RAP2C.
最近的一项研究报告了心肌成纤维细胞(CFs)在缺血再灌注损伤(IRI)急性期介导的心脏保护作用。目前还不清楚外泌体/微泡是否介导了这种有益作用,以及缺血后处理(Postcon)是否可以调节这一过程。在这里,我们旨在研究 CFs-外泌体/微泡的心脏保护作用,以及 Postcon 是否可以调节这种作用。
通过使用 Transwell 共培养系统,我们发现缺氧复氧(H/R)显著增加了 CFs 的外泌体/微泡分泌,CFs 可保护 H9C2 细胞免受 H/R 损伤,Postcon 可放大这些作用。抑制 CFs 外泌体/微泡的分泌导致 H/R-Postcon 放大的保护作用显著减弱。我们进一步证明,Postcon 增强了 CFs-外泌体/微泡在体外和体内的心脏保护作用。为了检测潜在的机制,通过 RNA 测序和定量聚合酶链反应分析了外泌体/微泡中的 microRNAs,我们的结果表明,Postcon 选择性地上调了 CFs 外泌体/微泡中的 miR-423-3p 表达。通过与富含 miR-423-3p 的 CFs-外泌体/微泡共培养 H9C2 细胞,我们证明 H/R-Postcon 通过上调 CFs-外泌体/微泡中的 miR-423-3p 发挥心脏保护作用。RNA 荧光原位杂交和 qPCR 表明,miR-423-3p 的减少与 IRI 密切相关,通过体内用其反义寡核苷酸抑制 miR-423-3p 的表达,我们证明 miR-423-3p 在体内 I/R-Postcon 诱导的 I/R 中发挥了至关重要的介导作用,Postcon 可能通过上调 CFs 外泌体/微泡中的 miR-423-3p 发挥心脏保护作用。增益和功能丧失方法表明,挽救下调的 miR-423-3p 可能是保护心肌细胞免受 H/R 的潜在策略。通过计算预测工具和荧光素酶报告基因检测,我们证明 miR-423-3p 在 H9C2 细胞中调节 Ras 相关蛋白 Rap-2c(RAP2C)的表达,并且 siRNA 敲低 RAP2C 明显增加了 H9C2 细胞在 H/R 下的细胞活力并减少了细胞凋亡。
总之,我们首次证明,CFs 通过外泌体/微泡途径在 IRI 的急性期参与心脏保护作用,Postcon 可以通过上调 CFs 外泌体/微泡 miR-423-3p 的表达来增强这种作用,miR-423-3p 靶向下游效应子 RAP2C。